Latest Comments

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

Pfizer seeking a timely re-launch of Mylotarg in AML amid increasing competition

Pfizer seeking a timely re-launch of Mylotarg in AML amid increasing competition

Despite Trump's surprising stance, drug prices will continue to rise in the US

Despite Trump's surprising stance, drug prices will continue to rise in the US

Trump’s plan to move drug manufacturing back to the US may take 10 years

Trump’s plan to move drug manufacturing back to the US may take 10 years

The emergence of oncology biosimilars

The emergence of oncology biosimilars

Rule-breakers: rehabilitating wayward clinical researchers

Rule-breakers: rehabilitating wayward clinical researchers

Could copper unlock a new wave of metabolic treatments?

Could copper unlock a new wave of metabolic treatments?